Cargando…
Anemia and Iron Deficiency in Outpatients with Inflammatory Bowel Disease: Ubiquitous Yet Suboptimally Managed
Background: Iron deficiency (ID) and anemia in patients with Inflammatory Bowel Disease (IBD) are associated with a reduced quality of life. We assessed the prevalence of ID and anemia in Dutch outpatients with IBD and compared routine ID(A) management among medical professionals to the European Cro...
Autores principales: | Loveikyte, Roberta, Boer, Menno, van der Meulen, Catharina N., ter Steege, Rinze W. F., Tack, Greetje, Kuyvenhoven, Johan, Jharap, Bindia, Vu, My K., Vogelaar, Lauran, West, Rachel L., van der Marel, Sander, Römkens, Tessa E. H., Mujagic, Zlatan, Hoentjen, Frank, van Bodegraven, Adriaan A., van Schaik, Fiona D. M., de Vries, Annemarie C., Dijkstra, Gerard, van der Meulen-de Jong, Andrea E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9692778/ https://www.ncbi.nlm.nih.gov/pubmed/36431320 http://dx.doi.org/10.3390/jcm11226843 |
Ejemplares similares
-
Real‐world experience of switching from intravenous to subcutaneous vedolizumab maintenance treatment for inflammatory bowel diseases
por: Volkers, Adriaan, et al.
Publicado: (2022) -
The effect of iron therapy on oxidative stress and intestinal microbiota in inflammatory bowel diseases: A review on the conundrum
por: Loveikyte, R., et al.
Publicado: (2023) -
The impact of biologics on health-related quality of life in patients with inflammatory bowel disease
por: Vogelaar, Lauran, et al.
Publicado: (2009) -
Effectiveness and safety of tofacitinib for ulcerative colitis: two‐year results of the ICC Registry
por: Straatmijer, Tessa, et al.
Publicado: (2022) -
Comment on Szczubełek et al. Effectiveness of Crohn’s Disease Exclusion Diet for Induction of Remission in Crohn’s Disease Adult Patients. Nutrients 2021, 13, 4112
por: van Lingen, Emilie, et al.
Publicado: (2022)